Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 218Triple Negative Breast Neoplasms 17Carcinoma, Intraductal, Noninfiltrating 15Breast Neoplasms, Male 15Inflammatory Breast Neoplasms 13Lung Neoplasms 11Prostatic Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Breast Carcinoma In Situ 9Brain Neoplasms 9Carcinoma, Ductal, Breast 7Melanoma 6Carcinoma, Non-Small-Cell Lung 6Recurrence 5Rectal Neoplasms 4Radiation Injuries 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Renal Cell 4Carcinoma, Lobular 4Burkitt Lymphoma 4Testicular Neoplasms 3

Interventions

Fulvestrant 19Letrozole 10Anastrozole 8Capecitabine 5palbociclib 4olaparib 4Paclitaxel 4Injections 4Goserelin 4Docetaxel 4trastuzumab deruxtecan 3pyrotinib 3exemestane 3Vinorelbine 3Aromatase Inhibitors 3toripalimab 2sacituzumab govitecan 2ribociclib 2eribulin 2elacestrant 2dalpiciclib 2abemaciclib 2Trastuzumab 2Gonadotropin-Releasing Hormone 2FCN-437c 2Everolimus 2Dasatinib 2Alpelisib 2Albumin-Bound Paclitaxel 2AZD9833 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Radiotherapy × Breast × Clear all
NCT06776861 2025-01-15

A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
150 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡